Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed + Carboplatin in Recurrent Ovarian or Primary Peritoneal Cancer
NCT00489359Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2005
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of pemetrexed in ovarian cancer, primary peritoneal cancer (PPC), sponsored by Eli Lilly and Company. Started Jul 2005; status: completed.
02
Drugs
pemetrexed
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00489359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489359.